These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 34666670

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. MicroRNA -383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1.
    Azarbarzin S, Hosseinpour-Feizi MA, Banan Khojasteh SM, Baradaran B, Safaralizadeh R.
    Life Sci; 2021 Feb 15; 267():118939. PubMed ID: 33359245
    [Abstract] [Full Text] [Related]

  • 23. MicroRNA-98-5p modulates cervical cancer progression via controlling PI3K/AKT pathway.
    Xiao R, Wang H, Yang B.
    Bioengineered; 2021 Dec 15; 12(2):10596-10607. PubMed ID: 34895048
    [Abstract] [Full Text] [Related]

  • 24. HPV-induced Nurr1 promotes cancer aggressiveness, self-renewal, and radioresistance via ERK and AKT signaling in cervical cancer.
    Wan PK, Leung TH, Siu MK, Mo XT, Tang HW, Chan KK, Cheung AN, Ngan HY.
    Cancer Lett; 2021 Jan 28; 497():14-27. PubMed ID: 33010383
    [Abstract] [Full Text] [Related]

  • 25. Williams syndrome transcription factor promotes proliferation and invasion of cervical cancer cells by regulating PI3K/Akt signaling pathway.
    Jiang D, Ren C, Yang L, Li F, Yang X, Zheng Y, Ji X, Tian Y.
    J Obstet Gynaecol Res; 2021 Jul 28; 47(7):2433-2441. PubMed ID: 34028125
    [Abstract] [Full Text] [Related]

  • 26. MiR-873/PD-L1 axis regulates the stemness of breast cancer cells.
    Gao L, Guo Q, Li X, Yang X, Ni H, Wang T, Zhao Q, Liu H, Xing Y, Xi T, Zheng L.
    EBioMedicine; 2019 Mar 28; 41():395-407. PubMed ID: 30803931
    [Abstract] [Full Text] [Related]

  • 27. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
    Wang Q, Song R, Zhao C, Liu H, Yang Y, Gu S, Feng D, He J.
    Int J Cancer; 2019 Apr 01; 144(7):1619-1632. PubMed ID: 30230542
    [Abstract] [Full Text] [Related]

  • 28. Keratinocyte differentiation factor 1 enhances cervical cancer cell viability and migration by activating the PI3K/AKT pathway.
    Chen C, Liao J, Sun X.
    J Obstet Gynaecol; 2024 Dec 01; 44(1):2362420. PubMed ID: 38864525
    [Abstract] [Full Text] [Related]

  • 29. Synergistic antitumor effect on cervical cancer by rational combination of PD1 blockade and CRISPR-Cas9-mediated HPV knockout.
    Zhen S, Lu J, Liu YH, Chen W, Li X.
    Cancer Gene Ther; 2020 Apr 01; 27(3-4):168-178. PubMed ID: 31455836
    [Abstract] [Full Text] [Related]

  • 30. LINC00673 exerts oncogenic function in cervical cancer by negatively regulating miR-126-5p expression and activates PTEN/PI3K/AKT signaling pathway.
    Shi WJ, Liu H, Ge YF, Wu D, Tan YJ, Shen YC, Wang H, Xu H.
    Cytokine; 2020 Dec 01; 136():155286. PubMed ID: 32950808
    [Abstract] [Full Text] [Related]

  • 31. Expressions of programmed death (PD)-1 and PD-1 ligand (PD-L1) in cervical intraepithelial neoplasia and cervical squamous cell carcinomas are of prognostic value and associated with human papillomavirus status.
    Yang W, Lu YP, Yang YZ, Kang JR, Jin YD, Wang HW.
    J Obstet Gynaecol Res; 2017 Oct 01; 43(10):1602-1612. PubMed ID: 28833798
    [Abstract] [Full Text] [Related]

  • 32. HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway.
    Wang M, Qiao X, Cooper T, Pan W, Liu L, Hayball J, Lin J, Cui X, Zhou Y, Zhang S, Zou Y, Zhang R, Wang X.
    Cell Death Dis; 2020 Dec 11; 11(12):1049. PubMed ID: 33311486
    [Abstract] [Full Text] [Related]

  • 33. Regulation of cervical cancer via G15-mediated inhibition of G protein-coupled estrogen receptor.
    Zhu Z, Nie X, Deng L, Ding J, Chen J, Zhu J, Yin X, Guo B, Zhang F.
    Anticancer Drugs; 2024 Oct 01; 35(9):817-829. PubMed ID: 39018257
    [Abstract] [Full Text] [Related]

  • 34. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.
    Hirao N, Iwata T, Tanaka K, Nishio H, Nakamura M, Morisada T, Morii K, Maruyama N, Katoh Y, Yaguchi T, Ohta S, Kukimoto I, Aoki D, Kawakami Y.
    Gynecol Oncol; 2019 Nov 01; 155(2):340-348. PubMed ID: 31477279
    [Abstract] [Full Text] [Related]

  • 35. Myosin 1b promotes cell proliferation, migration, and invasion in cervical cancer.
    Zhang HR, Lai SY, Huang LJ, Zhang ZF, Liu J, Zheng SR, Ding K, Bai X, Zhou JY.
    Gynecol Oncol; 2018 Apr 01; 149(1):188-197. PubMed ID: 29395313
    [Abstract] [Full Text] [Related]

  • 36. JARID2 activation by NFYA promotes stemness of triple-negative breast cancer cells through the PI3K/AKT pathway.
    Li J, Zhang X, Liu X, Ma X, Wang Y, Liu Y.
    Expert Rev Anticancer Ther; 2024 Oct 01; 24(10):1029-1040. PubMed ID: 39254227
    [Abstract] [Full Text] [Related]

  • 37. NDAT Targets PI3K-Mediated PD-L1 Upregulation to Reduce Proliferation in Gefitinib-Resistant Colorectal Cancer.
    Huang TY, Chang TC, Chin YT, Pan YS, Chang WJ, Liu FC, Hastuti ED, Chiu SJ, Wang SH, Changou CA, Li ZL, Chen YR, Chu HR, Shih YJ, Cheng RH, Wu A, Lin HY, Wang K, Whang-Peng J, Mousa SA, Davis PJ.
    Cells; 2020 Aug 03; 9(8):. PubMed ID: 32756527
    [Abstract] [Full Text] [Related]

  • 38. Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) pathway.
    Song L, Liu S, Zhao S.
    Bioengineered; 2022 Apr 03; 13(4):11240-11257. PubMed ID: 35485300
    [Abstract] [Full Text] [Related]

  • 39. Elevated MYO10 Predicts Poor Prognosis and its Deletion Hampers Proliferation and Migration Potentials of Cells Through Rewiring PI3K/Akt Signaling in Cervical Cancer.
    He JH, Chen JG, Zhang B, Chen J, You KL, Hu JM, Xu JW, Chen L.
    Technol Cancer Res Treat; 2020 Apr 03; 19():1533033820936773. PubMed ID: 32618228
    [Abstract] [Full Text] [Related]

  • 40. HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K/AKT signaling pathway in MDA-MB-231 breast cancer cells.
    Amornsupak K, Thongchot S, Thinyakul C, Box C, Hedayat S, Thuwajit P, Eccles SA, Thuwajit C.
    BMC Cancer; 2022 May 24; 22(1):578. PubMed ID: 35610613
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.